Fig. 5From: European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 1: amitriptylineThe forest plot shows pooled relative risk and associated confidence intervals comparing 50% or more reduction in monthly migraine days for amitriptyline versus placeboBack to article page